An 11-year-old girl will spend Christmas with her family once again having been declared cancer-free. Lola, from Thundersley ...

A new study suggests that neural crest cells are reprogrammed into tumor-forming cells, reshaping the understanding of this childhood cancer. LOS ANGELES--(BUSINESS WIRE)--A groundbreaking study led ...

“This was difficult information to hear, and it was not sugar- coated,” said Gracie Butler, who was told she had spindle cell sarcoma Teenage Cancer Trust Gracie Butler was 18 when she started ...

1 Department of Pathology, Taihe Hospital, Hubei University of Medicine, Shiyan, China 2 Department of Pathology, Zhuxi People’s Hospital, Shiyan, China Spindle cell epithelioma of the vagina (SCEV) ...

Now through June 13, customers at the Moncks Corner location at 469 N Highway 52 can donate any amount to support sarcoma cancer research. As a thank-you, donors will receive a $3 coupon toward their ...

Clear Cell Sarcoma (CCSA) is a rare soft tissue sarcoma characterized by specific gene fusions EWSR1::ATF1 or EWSR1::CREB1, leading to the expression of an oncogenic fusion protein. Metastasized CCSA ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Correct mitotic spindle alignment is essential ...

'The Best Girl Dad:' Emil Lobosco Of Passaic County Dies After Cancer Battle, 58 Emil Lobosco, a cherished Pompton Lakes resident known for his infectious joy and love for life, passed away on Friday, ...

Emil Lobosco, a cherished Pompton Lakes resident known for his infectious joy and love for life, passed away on Friday, Dec. 20, following a battle with spindle cell sarcoma. He was 58 years old. “To ...

Letetresgene autoleucel (lete-cel) showed a 42% response rate in a phase 2 trial for synovial sarcoma and myxoid/round cell liposarcoma. The trial included 64 patients, with 41% response in synovial ...

Adaptimmune Therapeutics is prepping for another FDA submission after 42% of patients with sarcoma responded to the company's investigational cell therapy in a pivotal phase 2 trial. The primary ...

This article first appeared with Targeted Oncology™. An orphan drug designation (ODD) was granted by the FDA to elraglusib for the treatment of patients with soft tissue sarcoma (STS). 1 Currently, a ...